Starting on the phone. Expanding into every device that touches an animal.
We are building for the world, first of its kind.
Eko Health has sold 700,000 digital stethoscopes, raised $41M, and earned 9 FDA clearances for AI-augmented cardiac auscultation in humans. In 2025, they entered veterinary care — but only for heart murmurs.
Respiratory acoustics — cough, stertor, wheeze, breath harshness — remains untouched. It requires species-specific acoustic taxonomy, not just algorithm adaptation.
Cardiac-first. Human-centric. Hardware-dependent. Veterinary entry: heart murmurs only.
Respiratory-first. Species-native from day one. Software-only. Breed-scaled analysis across all breeds.
A veterinarian places a stethoscope on a dog's chest. They hear harsh breathing. They note it. But they cannot answer the question that matters: Is this harsher than it should be for this dog, at this breathing rate, of this breed, at this age?
In its first version, you use your phone. Hold it near your dog, press record for eight seconds, and the technology separates breathing from room noise, identifies each sound event, measures it, and compares it against what is expected for that breed, age, and breathing rate.
The same technology can be built into a telemedicine app via API, integrated into a smart collar for continuous monitoring, or embedded in a purpose-built veterinary stethoscope.
The instrument compares harshness against what is expected for this exact breathing rate, breed, age, and weight — not a generic average.
The phone's own distortion cancels out mathematically when comparing today's recording to last week's. No calibration required.
Every measurement is scaled against breed-specific acoustic norms derived from published veterinary anatomy research.
When the signal is too noisy or ambiguous, the instrument says so. It withholds metrics rather than invent them.
| Dimension | Eko Health | Bodh Informatics |
|---|---|---|
| Organ system | Heart + lungs | Respiratory only |
| Species focus | Humans + dogs (heart only) | Dogs (respiratory, all breeds) |
| Hardware | Physical device required ($379) | Software-only — any phone |
| Breed specificity | None | Breed-scaled analysis |
| Output architecture | Black-box AI | Auditable pattern recognition |
| Price model | Hardware + subscription | Per-usage / API licensing |
Clinical validation with veterinary partners. The reference database seeds the learning corpus.
Telemedicine platforms integrate Fauna Acoustic. Wearable manufacturers license the acoustic IP.
Integration into IoT stethoscopes, USB-C microphones, and smart collars.
Bodh designs and manufactures its own wearable device. End-to-end control.
Do you know a veterinary researcher, a clinic owner, or an IP attorney who works in biotech? Warm introductions matter more than cold emails.
Where does this pitch fall apart? Which assumption is weakest? We need honest pushback, not validation.
If this resonates, we are looking for advisors and early clinical partners. Not capital yet — validation and network.
You have seen products succeed and fail. Does this feel like a real problem with a real solution?